Olema Pharmaceuticals (OLMA) announced late Tuesday its plans for a public offering of common stock and pre-funded warrants.
The company said underwriters will have a 30-day option to purchase an additional 15% of the shares, including those underlying the pre-funded warrants.
Olema added that there is no assurance regarding the timing, size, or completion of the proposed offering.
Shares of the company were down 2.4% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.